Lookback study in Japan
Download
Report
Transcript Lookback study in Japan
Lookback study for transfusionrelated HBV infection in Japan
Tokyo Metropolitan Red Cross Blood Center
Masahiro Satake
Lookback study in Japan
• Aliquots from all donations have been stored
since 1997.
• When necessary, each aliquot was investigated
using individual donation-NAT (ID-NAT).
• Subjects for the study :
converters for HBs-Ag, HBc-Ab, HCV-Ab,
HIV-Ab, screening NAT for HBV, HCV or HIV
during April 1999 and February 2005
ID-NAT results in repository tubes from
seroconverted or NAT-converted donors
No. of ID-NAT
performed
No. of positive
tubes
Positivity rate
(%)
HBV
20,033
261
1.30
HCV
4,371
2
0.05
HIV
1,673
1
0.06
total
26,077
264
1.01
(‘99 April ~ ’05 February)
No. of HBV ID-NAT positive but pool-NAT
negative donors estimated by lookback study
Conversion /
year
ID-NAT positive
No. of ID-NAT
positive donors
HBV-pool
NAT
80
3.75%
3.0
HBs-Ag
124
3.7%
4.6
HBc-Ab
3269
1.0%
32.6
total
3473
1.16%
40.2
These donations do not directly relate to infectivity.
The infectivity of HBV-ID-NAT positive components
No. of ID-NAT positive donation
No. of components released
transfused・・・・・・・・・・・
discarded・・・・・・・・・・・
unknown・・・・・・・・・・・
267
321
293
16
12
Outcome of transfused patients(191 reports available )
HBs-Ag conversion
6
HBV-DNA conversion
2
HBs-Ab conversion
3
positive, but no information before transfusion 7
markers not changed
60
dead
99
discharged etc.
14
The infectivity of HBV-ID NAT-positive components
HBV infected 11
Undetermined 7
No change
60
others
115
Infectious risk when
transfused with ID-NAT
positive blood
11/78~18 /78
6~10 HBV infections per year
Infectivity of HBV ID-NAT positive components
Component
Infected
No
change
Window
period
10
21
31
32% (10/31)
1
39
40
2.5% (1/40)
total
infectivity
(HBcAb -)
Chronic
carrier
(HBcAb +)
Infectivity of W.P. component is 13 times as high as that from chronic carrier.
Implicated components
component
RBC
FFP
Platelet
From window From chronic
period
carrier
5 / 10
(50%)
0 / 19
3 / 10
1 / 18
(30%)
(6%)
2/4
(50%)
0/1
Established cases for HBV infection
Disorders of patients
hematologic malignancy
gastric cancer
dissecting aortic aneurysm
shock due to multiple trauma
rheumatoid arthritis
unknown
2
2
1
1
1
4
ID-NAT in repository tubes
--- voluntarily reported HBV cases --100
4
virus (+)
virus (-)
4
unknown
5
6
75
4
57
31
36
1999
2000
42
0
2001
2002
2003
The risk of HBV infection under current
screening algorism including 50p-NAT system
Sources
HBV-infection
Lookback investigation
6~10
Voluntary report of infection
5
total
11~15 cases/year
Lookback study for HCV and HIV
No. of ID-NAT
performed
HCV
4,371
HIV
1,673
No. of positive tubes
2
(1 donation before NAT
implementation)
1
(Established infected case)
Seroconversion possibly due to nonspecific reaction was
also subjected to lookback study.
Estimates for the Occurrence of TransfusionTransmitted Viral Diseases in Japan
• HBV
HBV+ donation detectable only by ID-NAT : 1 / 150,000
11~15 infection cases per year
(1 infection / 3.6~5.4 x 105 components)
• HCV (difficult to estimate)
HCV+ donation detectable only by ID-NAT : 1 / 24 million
(1 component / 4 years)
• HIV (difficult to estimate)
HIV+ donation detectable only by ID-NAT : 1 / 12 million
(1 component / 2 years)